---
figid: PMC3797025__jnci.j_djt263_f0007
figlink: /pmc/articles/PMC3797025/figure/F7/
number: F7
caption: Schematic model of adaptive primary resistant responses by tumors to anti–IGF-1R
  monoclonal antibodies (mAbs). IGF/IGF-1R interaction stimulates downstream pathway
  with tumor progression. Tumors respond to IGF/IGF-1R pathway inhibition with anti–IGF-1R
  mAb, but mechanisms of primary resistance to the treatment are induced via alternative
  proliferative and survival signals through IGF/integrin β3 interaction and integrin-Src
  signaling cascade. Targeting integrin β3 or Src overcomes resistance to anti–IGF-1R
  mAbs. IGF-1R = insulin-like growth factor 1 receptor.
pmcid: PMC3797025
papertitle: Combating Resistance to Anti-IGFR Antibody by Targeting the Integrin β3-Src
  Pathway.
reftext: Dong Hoon Shin, et al. J Natl Cancer Inst. 2013 Oct 16;105(20):1558-1570.
pmc_ranked_result_index: '59344'
pathway_score: 0.9470642
filename: jnci.j_djt263_f0007.jpg
figtitle: Schematic model of adaptive primary resistant responses by tumors to anti–IGF-1R
  monoclonal antibodies (mAbs)
year: '2013'
organisms: Homo sapiens
ndex: 267f4d36-de9d-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3797025__jnci.j_djt263_f0007.html
  '@type': Dataset
  description: Schematic model of adaptive primary resistant responses by tumors to
    anti–IGF-1R monoclonal antibodies (mAbs). IGF/IGF-1R interaction stimulates downstream
    pathway with tumor progression. Tumors respond to IGF/IGF-1R pathway inhibition
    with anti–IGF-1R mAb, but mechanisms of primary resistance to the treatment are
    induced via alternative proliferative and survival signals through IGF/integrin
    β3 interaction and integrin-Src signaling cascade. Targeting integrin β3 or Src
    overcomes resistance to anti–IGF-1R mAbs. IGF-1R = insulin-like growth factor
    1 receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CD
  - AKT3
  - AKT2
  - BHLHE22
  - RAF1
  - PIK3R4
  - AKT1
  - PIK3CA
  - PIK3R5
  - PIK3CG
  - PTK2
  - MAPK3
  - PIK3CB
  - BRAF
  - HRAS
  - EGFR
  - PIK3R3
  - PIK3R6
  - ARAF
  - KRAS
  - MTOR
  - IGF1
  - IGF1R
  - MAPK1
  - SRC
  - NRAS
  - Cancer
  - Lung cancer
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: B3
  symbol: Beta3
  source: hgnc_alias_symbol
  hgnc_symbol: BHLHE22
  entrez: '27319'
- word: RAS/RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: RAS/RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS/RAF
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS/RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAS/RAF
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: RAS/RAF
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC3797025__F7
redirect_from: /figures/PMC3797025__F7
figtype: Figure
---
